Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

FINANCIAL INSTRUMENTS (Narrative) (Details)

v3.21.1
FINANCIAL INSTRUMENTS (Narrative) (Details)
$ / shares in Units, € in Thousands, $ in Thousands, $ in Thousands
 1 Months Ended 2 Months Ended 12 Months Ended
Jun. 30, 2020
CAD ($)
$ / shares
shares
Dec. 26, 2019
CAD ($)
shares
Dec. 26, 2019
USD ($)
shares
Aug. 29, 2019
CAD ($)
Shares
$ / shares
shares
Jun. 30, 2018
CAD ($)
$ / shares
shares
Dec. 31, 2020
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2020
USD ($)
Shares
shares
Dec. 31, 2019
CAD ($)
Shares
$ / shares
Dec. 31, 2020
EUR (€)
Shares
Dec. 31, 2018
CAD ($)
Disclosure of detailed information about financial instruments [line items]                    
Exercise price of warrants exercisable | $ / shares           $ 1.3        
Net proceeds from private placement               $ 15,570    
Issuance expenses including FV of compensation units               2,913    
Finance costs           $ 20,504   $ 707    
Exercise price of compensation option | $ / shares           $ 0.45   $ 0    
Number of share options granted in share-based payment arrangement | Shares           3,620,000 3,620,000 12,300,000    
Weighted average exercise price of share options granted in share-based payment arrangement | $ / shares           $ 1.06   $ 0.40    
Number of warrants exercised | Shares           12,351,795 12,351,795      
Aggregate consideration to acquire preferred shares           $ 1,347   $ 912    
Investments           2,341   912    
Investments in unlisted shares measured at fair value           2,341        
Cash and cash equivalents           8,885   13,926   $ 7,591
Warrants And Compensation Options [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Finance costs $ 3,675                  
Proceeds from warrants and compensation options exercised $ 6,032                  
Number of warrants and compensation options exercised | shares 12,350,795                  
Percentage of warrants and Compensation options exercised 92.10%                  
Exercise price of warrants exercised | $ / shares $ 0.50                  
Exercise price of compensation option | $ / shares $ 0.40                  
2018 Warrants [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Fair value of warrants           $ 3,872   $ 197    
Exercise price of warrants exercised | $ / shares           $ 0.50        
Number of warrants outstanding | Shares             11,413,750  
Exercise price of compensation option | $ / shares           $ 0.40        
(Gain) loss on revaluation           $ 3,675   $ (856)    
Number of warrants exercised | Shares           12,350,795 12,350,795      
Compensation units [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Number of compensation units converted to ordinary shares | shares           327,780 327,780      
Number of warrants issued upon conversion | shares           163,890 163,890      
Value of compensation units converted to ordinary shares and warrants           $ 344        
2019 Warrants [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Fair value of warrants           $ 16,540      
Exercise price of warrants exercised | $ / shares           $ 1.3        
Number of warrants outstanding | Shares           9,729,264   9,730,264 9,729,264  
(Gain) loss on revaluation           $ 16,283   $ (2,597)    
Number of warrants exercised | Shares           1,000 1,000      
Number of warrants converted to ordinary shares | shares           1,000 1,000      
Value of warrants converted to ordinary shares           $ 1        
Conversion price per warrant | $ / shares           $ 1.3        
Private Placements [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Number of units issued | shares       19,460,527            
Number of units issued, price per share | $ / shares       $ 1.05            
Gross proceeds from issuance of units       $ 20,433            
IMC [Member] | Private Placements [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Number of units issued | shares       19,460,527 2,282,749          
Number of units issued, price per share | $ / shares       $ 1.05 $ 4.00          
Gross proceeds from issuance of units       $ 20,433 $ 9,131          
Exercise price of warrants exercisable | $ / shares       $ 1.3 $ 5.00          
Term of warrants from date of issuance       24 months 24 months          
Fees and other issuance expenses       $ 2,596 $ 874          
Net proceeds from private placement       17,837 8,257          
Fair value of warrants       2,597 1,278          
Proceeds from issue of ordinary shares       17,836 $ 7,853          
Number of compensation warrants granted to agents | shares         128,652          
Issuance expenses including FV of compensation units       3,337            
Finance costs       424 $ 123          
Reduction of share premium, cost allocated to Ordinary shares       $ 2,913 $ 751          
IMC [Member] | Private Placements [Member] | Compensation units [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Exercise price of warrants exercisable | $ / shares       $ 1.3            
Term of warrants from date of issuance       36 months            
Number of share options granted in share-based payment arrangement | Shares       1,199,326            
Weighted average exercise price of share options granted in share-based payment arrangement | $ / shares       $ 1.05            
Fair value of compensation units       $ 741            
Navasota Shareholders [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Exercise price of warrants exercised | $ / shares           $ 0.283        
Number of warrants outstanding | Shares           0   706,713 0  
Number of warrants exercised | Shares           113,520 113,520      
Xinteza Api Ltd [Member] | Share Purchase Agreement [Member] | Convertible preferred shares [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Number of preferred shares committed to acquire | shares   38,000 38,000              
Aggregate consideration to acquire preferred shares     $ 1,700              
Percentage of outstanding share capital for preferred shares to be acquired   24.20% 24.20%              
Xinteza Api Ltd [Member] | First installment [Member] | Share Purchase Agreement [Member] | Convertible preferred shares [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Number of preferred shares committed to acquire | shares   15,700 15,700              
Aggregate consideration to acquire preferred shares   $ 912 $ 700              
Xinteza Api Ltd [Member] | Remaining installment [Member] | Share Purchase Agreement [Member] | Convertible preferred shares [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Number of preferred shares committed to acquire | shares           22,401 22,401      
Aggregate consideration to acquire preferred shares           $ 1,347 $ 1,000      
Currency risk [Member]                    
Disclosure of detailed information about financial instruments [line items]                    
Cash and cash equivalents           738     € 472  
Financial liabilities           $ 4,188